Abstract
This paper introduces an innovative method for fine-tuning a larger multi-label model for abnormality detection, utilizing a smaller trainer and advanced knowledge distillation techniques. It delves into the effects of fine-tuning on various abnormalities, noting varied improvements based on the Original Model’s performance in specific tasks. The experimental setup, optimized for on-device inference and fine-tuning with limited computational resources, demonstrates moderate yet promising enhancements in model performance post-fine-tuning. Key insights from the study include the importance of aligning the µ-Trainer’s behavior with the Original Model and the influence of hyper-parameters like the batch size on fine-tuning outcomes. The research acknowledges limitations such as the limited exploration of loss functions in multi-label models and constraints in architectural design, suggesting potential avenues for future investigation. While the proposed Naive Continual Fine-tuning Process is in its early stages, it highlights the potential for long-term model personalization. Moreover, using weight transfer exclusively for fine-tuning amplifies user privacy protection through on-device fine-tuning, devoid of transferring data or gradients to the server. Despite modest performance improvements after fine-tuning, these layers represent a small fraction (0.7%) of the total weights in the Original Model and 1.6% in the µ-Trainer. This study establishes a foundational framework for advancing personalized model adaptation, on-device inference, and fine-tuning while emphasizing the importance of safeguarding data privacy in model development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This research paper uses the public CPSC dataset but acknowledges that the TNMG dataset is private and requires permission from its owner for access.